reviewCancer Treatment ReviewsFeb 6, 2016Closed access

Management of toxicities of immune checkpoint inhibitors

LSLavinia SpainSDStefan DiemJLJames Larkin

Royal Marsden NHS Foundation Trust

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

853
total citations
FWCI
56.44
Percentile
100%
References
90
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Ipilimumab
  • Medicine
  • Nivolumab
  • Pembrolizumab
  • Adverse effect
  • Melanoma
  • Lung cancer
  • Oncology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.